Clinical Trial

A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function

Name: A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function — clinical trial record (NCT07322016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate pharmacokinetics of HRS-1301 tablets in subjects with impaired kidney function in comparison with healthy subjects, to develop dose recommendations for patients with renal impairment.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-14

Trial Details

NCT Number	NCT07322016
Lead Sponsor	Shandong Suncadia Medicine Co., Ltd.
Conditions	Hyperlipidemias
Enrollment	36 participants
Start Date	2026-01-13
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-05-13